Otsu, Japan

Mie Yabuuchi

This inventor holds 1 USPTO granted patent. Top assignee: Takara Bio Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mie Yabuuchi. Retrieved from https://idiyas.com/inventor/mie-yabuuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mie Yabuuchi: Innovator in Natural Killer Cell Production

Introduction

Mie Yabuuchi is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of cellular biology, particularly in the production of natural killer cells. His innovative work has implications for various therapeutic applications.

Latest Patents

Yabuuchi holds a patent for a "Process for production of natural killer cells." This process involves the expansion culture of a cell mass containing natural killer cells and/or cells capable of being differentiated into natural killer cells. The method is characterized by the presence of a biological response modifier and cells that have been treated to lose their proliferation capability. This patent highlights his expertise in advancing cellular therapies.

Career Highlights

Throughout his career, Yabuuchi has been associated with Takara Bio Inc., a company known for its focus on biotechnology and life sciences. His work at the company has allowed him to explore innovative solutions in cell production and manipulation.

Collaborations

Yabuuchi has collaborated with talented coworkers, including Mitsuko Ideno and Meiko Jin. Their combined efforts contribute to the advancement of research in cellular biology and therapeutic applications.

Conclusion

Mie Yabuuchi's contributions to the field of natural killer cell production exemplify the importance of innovation in biotechnology. His patent and work at Takara Bio Inc. reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…